Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 7Gastrointestinal 3Thoracic 1Other solid neoplasm 1

Conditions

Stomach Neoplasms 1Peritoneal Neoplasms 1Neoplasm Metastasis 1Mesothelioma 1Colorectal Neoplasms 1

Interventions

Injections 17Cisplatin 15Carboplatin 15Oxaliplatin 11Gemcitabine 11pembrolizumab 8Capecitabine 8toripalimab 7Paclitaxel 7Etoposide 7Cyclophosphamide 7Pemetrexed 6Irinotecan 6Drug Therapy 6spartalizumab 5fludarabine 5camrelizumab 5Vincristine 5Radiotherapy 5Leucovorin 5tislelizumab 4apatinib 4anlotinib 4Interleukin-2 4Immune Checkpoint Inhibitors 4Granulocyte-Macrophage Colony-Stimulating Factor 4Fluorouracil 4Docetaxel 4Bevacizumab 4tremelimumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Cytoreduction Surgical Procedures × Other solid neoplasm × Clear all
NCT00454519 2009-02-13

IPHC

Wuhan University

Phase 2 Unknown
60 enrolled
GastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Neoplasm Metastasis, Peritoneal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡